Overview
Oma Robotics (formerly Thread Robotics) is a medical technology company focused on fertility care. It operates in a business-to-business model, aiming to help fertility clinics and labs provide IVF and egg-freezing services more accessible and affordable by using artificial intelligence and robotics. Its technology automates critical laboratory procedures, including automated gamete selection and automated cell positioning, through hardware and software designed for fertility labs. The company differentiates itself with patents covering automated γamete selection and cell positioning, signaling a focus on end-to-end lab automation rather than consumer-facing devices. Its goal is to streamline laboratory workflows in fertility treatment to reduce costs and increase availability for patients. This company previously raised seed funding and planned to acquire operations, but ceased active operations in 2023, with its CEO indicating it did not file for bankruptcy at that time.
Work here?Claim your company
Simplify's take
What believers are saying
- 2026 job boards list active roles in San Francisco, St. Louis, Atlanta, and Manhattan.
- Justia shows Thread Robotics patents issued in 2022 and 2023, preserving licensing value.
- Oma Fertility still markets accessible IVF in 2026, supporting brand recognition and referral demand.
What critics are saying
- August 2023 reports said Thread Robotics was closing and selling clinics and labs.
- Dr. Zarek said OMA leaders withheld deterioration from physicians, damaging trust and retention.
- If clinic sales fail again, Oma loses revenue, customers, and an existential path to relevance.
What makes Oma Robotics unique
- Patented automated gamete selection and cell positioning still distinguish Thread Robotics from software-only fertility startups.
- Oma combines clinic operations with lab automation, giving direct workflow data and commercialization leverage.
- 2026 job postings keep the Oma Fertility brand alive despite earlier shutdown reports.
Help us improve and share your feedback! Did you find this helpful?